Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maj

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
Polish Journal of Pharmacology and Pharmacy|January 1, 1977
Sedative action of low doses of dopaminergic agentsJ Maj, B Przewlocka, L Kukulka
Przeglad Dermatologiczny|November 1, 1990
[Werner's Syndrome]T Kołodziej, J Maj, M Ziarkiewicz
Advances in Biochemical Psychopharmacology|January 1, 1974
The role of brain 5-hydroxytryptamine in the central action of L-DOPAJ Maj, L Pawlowski, J Sarnek
The Journal of Pharmacy and Pharmacology|September 1, 1972
The effect of L-dopa on neuroleptic-induced catalepsyJ Maj, Z Kapturkiewicz, J Sarnek
The Journal of Pharmacy and Pharmacology|December 1, 1971
Differences in the locomotor activity of mice as measured by an Animex and photoresis to actometerJ Maj, B Durek, W Palider
Journal of Neural Transmission (Vienna, Austria : 1996)|January 12, 2008
The involvement of cerebellar dopamine D3 receptors in locomotor activity of ratsW Kolasiewicz, J Maj, K Ossowska
Arzneimittel-Forschung|January 1, 1976
[Proceedings: On the central action of nomifensine (author's transl)]J Maj, Z Kapturkiewicz, J Michaluk
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activityJ Maj, G Skuza, Z Rogóz
Polish Journal of Pharmacology|May 1, 1993
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effectsJ Maj, Z Rogóz, G Skuza
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 1, 1986
[Treatment of auricular hematomas]J Maj, W Kaniuk, A Wolak
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
Polish Journal of Pharmacology and Pharmacy|January 1, 1977
Sedative action of low doses of dopaminergic agentsJ Maj, B Przewlocka, L Kukulka
Przeglad Dermatologiczny|November 1, 1990
[Werner's Syndrome]T Kołodziej, J Maj, M Ziarkiewicz
Advances in Biochemical Psychopharmacology|January 1, 1974
The role of brain 5-hydroxytryptamine in the central action of L-DOPAJ Maj, L Pawlowski, J Sarnek
The Journal of Pharmacy and Pharmacology|September 1, 1972
The effect of L-dopa on neuroleptic-induced catalepsyJ Maj, Z Kapturkiewicz, J Sarnek
The Journal of Pharmacy and Pharmacology|December 1, 1971
Differences in the locomotor activity of mice as measured by an Animex and photoresis to actometerJ Maj, B Durek, W Palider
Journal of Neural Transmission (Vienna, Austria : 1996)|January 12, 2008
The involvement of cerebellar dopamine D3 receptors in locomotor activity of ratsW Kolasiewicz, J Maj, K Ossowska
Arzneimittel-Forschung|January 1, 1976
[Proceedings: On the central action of nomifensine (author's transl)]J Maj, Z Kapturkiewicz, J Michaluk
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activityJ Maj, G Skuza, Z Rogóz
Polish Journal of Pharmacology|May 1, 1993
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effectsJ Maj, Z Rogóz, G Skuza
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 1, 1986
[Treatment of auricular hematomas]J Maj, W Kaniuk, A Wolak
Pageof 23